Recs

12

These Stocks Can Easily Double Your Money

Many investors are gloating pretty loudly about their investment performance over the past year.

Who are these people, you ask? Shareholders of these 10 top-performing stocks:

Company

Dividend-Adjusted Increase
From Oct. 1, 2008, to Sept. 30, 2009

Market Capitalization
on Oct. 1, 2008

Opexa Therapeutics (Nasdaq: OPXA  )

2,056%

$2.0 million

Dollar Thrifty Automotive

1,148%

$42.6 million

Vanda Pharmaceuticals

1,113%

$25.6 million

Diedrich Coffee

1,103%

$10.9 million

Speedus

877%

$2.1 million

OncoGenex Pharmaceuticals

800%

$8.2 million

Astrotech (Nasdaq: ASTC  )

706%

$5.7 million

VocalTech Communications

597%

$2.1 million

Keryx Biopharmaceuticals (Nasdaq: KERX  )

588%

$15.3 million

Kirkland's

531%

$44.3 million

Data from Capital IQ, a division of Standard & Poor's.

Notice anything about those companies? They're small. Very small. Now compare their performance with the top 10 stocks of the S&P 500 index over the same time period:

Company

Dividend-Adjusted Increase
From Oct. 1, 2008, to Sept. 30, 2009

Micron Technology

91%

Western Digital

77%

Red Hat

77%

Cognizant Technology Solutions

75%

Tellabs (Nasdaq: TLAB  )

72%

Apple (Nasdaq: AAPL  )

70%

Ciena (Nasdaq: CIEN  )

68%

Broadcom (Nasdaq: BRCM  )

67%

Citrix Systems

65%

Genworth Financial

62%

Data from Capital IQ, a division of Standard & Poor's.

While the latter results are nothing to sneeze at, particularly given that the overall market lost roughly 12.5% over that period, wouldn't you rather have the former?

Where you'll find the double-baggers
Small caps' tendency to outperform their large-cap brethren isn't just a down-market happenstance -- it held true in 2005, 2006, 2007, and 2008, as well.

In any market, the stocks with the most potential for outsized returns (stocks that will double, triple, or even increase your investment tenfold) are not found among large caps, but rather among stocks that are:

  1. Ignored.
  2. Obscure.
  3. Very small.

Why? Because the market's greatest inefficiencies (and, thereby, greatest opportunities) lie hidden among the investments that Wall Street analysts and institutional investors shun only because of their size.

Starting today
Investing in small-cap stocks makes many people nervous -- and today's market volatility is sending many people into the arms of stable, financially pristine large-cap stocks. Which makes now an even better time to buy up shares of oversold small caps.

But not all small caps are equal. You want to make sure you buy small caps that have a rock-solid balance sheet and a solid business model. Both these factors ensure that the company will be around five to 10 years from now, giving it plenty of time to double, triple, or increase tenfold in size.

At Motley Fool Hidden Gems, these are precisely the kinds of stocks we're recommending right now -- and we're putting real money behind our best ideas. What's more, our recommendations are beating the market by an average of 21 percentage points since the service began in 2003.

If you'd like to see all the stocks that have made it into our portfolio, you can find out completely free. Click here for more information.

Already subscribe to Hidden Gems? Log in here.

This article was originally published June 2, 2009. It has been updated.

Adam J. Wiederman owns no shares of the companies mentioned above. Apple is a Motley Fool Stock Advisor recommendation. The Motley Fool's disclosure policy is a top performer.


Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On October 13, 2009, at 4:25 PM, nqian96 wrote:

    I'd like to comment on this:

    "At Motley Fool Hidden Gems, these are precisely the kinds of stocks we're recommending right now."

    HG recommends similar stocks. Technically the sentence is correct, but to my best knowledge HG has never recommended any of the stocks mentioned in this article.

  • Report this Comment On October 21, 2009, at 1:10 PM, lawrinson wrote:

    Is anyone following Neuralstem [CUR]? Small stem cell company that supposedly has applications for ALS (Lou Gehrig's Disease) as well as spinal cord damage. Some pretty wild gyrations in price over the last year, most recently after FDA approval for in-human studies. Animal studies fantastic. Is this a find or am I seeing a mirage?

Add your comment.

Compare Brokers

Fool Disclosure

DocumentId: 1005099, ~/Articles/ArticleHandler.aspx, 2/14/2012 2:40:14 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
DOW 12,792.00 -82.04 -0.64%
S&P 500 1,342.82 -8.95 -0.66%
NASD 2,917.90 -13.49 -0.46%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

2/14/2012 2:16 PM
KERX $3.30 Down -0.07 -2.08%
Keryx Biopharmaceu… CAPS Rating: ***
OPXA $1.08 Down -0.01 -0.92%
OPEXA THERAPEUTICS… CAPS Rating: ***
TLAB $3.85 Down -0.02 -0.52%
Tellabs, Inc. CAPS Rating: ****
CIEN $16.81 Up +0.37 +2.22%
Ciena Corp CAPS Rating: **
AAPL $504.52 Up +1.92 +0.38%
Apple CAPS Rating: ***
ASTC $0.74 Up +0.04 +5.71%
Astrotech Corporat… CAPS Rating: ***
BRCM $36.62 Down -0.20 -0.54%
Broadcom Corp CAPS Rating: ***

Advertisement